Severe B cell–mediated disease activation despite two cycles of alemtuzumab in a patient with multiple sclerosis - MyNeuroNews

Severe B cell–mediated disease activation despite two cycles of alemtuzumab in a patient with multiple sclerosis

Multiple Sclerosis Journal, Ahead of Print.

from WordPress https://ift.tt/2Owe7dQ

No comments:

Subscribe to: Post Comments (Atom)